Trial Profile
Safety and efficacy of bendamustine, lenalidomide and dexamethasone combination therapy in relapsed and refractory multiple myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2016
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 07 Sep 2016 New trial record